PATENT CLAIM ANALYSIS

Application Number: 16119995
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["435", "366000"]

Abstract:
The present invention provides methods to promote differentiation of pancreatic endoderm cells to pancreatic endocrine rich clusters and to enhance insulin expression in hormone-expressing cells.

Claim (Index 1):
A method for inducing formation of endocrine clusters, comprising culturing pancreatic endocrine cells with a sphingosine-1 receptor agonist.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 96.0
- Lexical Diversity: 1.18182
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16119862', '15340418', '13911829', '13998883', '13708369']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6117884228137795
- 35 USC 102 Novelty (BERT): 0.6144648241627197
- Combined Prediction Score: 0.6120560629486735
- Mean Citation Score: 560.149406
- Max Citation Score: 625.2811
- Similarity Product: 479.3694950444221

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test